or Try an Advanced Search...

    Technical Analysis for TIL - Instil Bio, Inc.

    Grade Last Price % Change Price Change
    D 11.26 0.09% 0.01
    TIL closed up 0.09 percent on Wednesday, May 8, 2024, on 25 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
    Earnings due: May 9
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Up
    Historical TIL trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Fell Below 50 DMA Bearish 0.09%
    Stochastic Sell Signal Bearish 0.09%
    Upper Bollinger Band Walk Strength 0.09%
    Outside Day Range Expansion 0.09%
    Older End-of-Day Signals for TIL ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 10 hours ago
    Possible Inside Day about 10 hours ago
    50 DMA Resistance about 12 hours ago
    Upper Bollinger Band Resistance about 12 hours ago
    Rose Above Upper Bollinger Band about 13 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TIL Chart by TradingView
    Basic chart:

    Profile

    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Cell Therapy Non Small Cell Lung Cancer Melanoma Lymphocytes Cervical Cancer Head And Neck Squamous Cell Carcinoma Tumor Infiltrating Lymphocytes Cutaneous Squamous Cell Carcinoma Therapies For The Treatment Of Patients With Cancer

    Is TIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 12 Jefferies cuts Instill Bio to hold, cites drug discontinuation
    Mar 27 What Makes Instil Bio (TIL) a New Buy Stock
    Mar 22 Instil Bio Non-GAAP EPS of -$1.26 beats by $2.14
    Mar 21 Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    Jan 18 Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
    Jan 17 Instil Bio hits four-month high on rising volumes
    Jan 16 Instil Bio Announces Strategic Update
    Dec 5 Instil Bio announces effective date of 1-for-20 reverse stock split
    Dec 5 Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
    Nov 14 Instil Bio Non-GAAP EPS of -$0.16 misses by $0.01
    See more TIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.46
    52 Week Low 6.07
    Average Volume 11,639
    200-Day Moving Average 9.43
    50-Day Moving Average 11.28
    20-Day Moving Average 10.81
    10-Day Moving Average 10.96
    Average True Range 0.46
    RSI (14) 55.36
    ADX 15.84
    +DI 22.35
    -DI 19.76
    Chandelier Exit (Long, 3 ATRs) 10.35
    Chandelier Exit (Short, 3 ATRs) 11.54
    Upper Bollinger Bands 11.49
    Lower Bollinger Band 10.12
    Percent B (%b) 0.83
    BandWidth 12.74
    MACD Line 0.05
    MACD Signal Line -0.07
    MACD Histogram 0.114
    Fundamentals Value
    Market Cap 73.23 Million
    Num Shares 6.5 Million
    EPS -30.20
    Price-to-Earnings (P/E) Ratio -0.37
    Price-to-Sales 55329.79
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 11.77
    Resistance 3 (R3) 11.83 11.71 11.69
    Resistance 2 (R2) 11.71 11.58 11.69 11.66
    Resistance 1 (R1) 11.49 11.50 11.43 11.43 11.63
    Pivot Point 11.37 11.37 11.35 11.35 11.37
    Support 1 (S1) 11.15 11.24 11.09 11.09 10.89
    Support 2 (S2) 11.03 11.16 11.01 10.86
    Support 3 (S3) 10.81 11.03 10.84
    Support 4 (S4) 10.75